Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?

Andreas Kronbichler; Philipp Gauckler; Keum Hwa Lee; Jae Il Shin; Paolo Malvezzi; Gert Mayer

doi:10.1016/j.atherosclerosissup.2019.08.027

Article2021

Plant-based vaccines and cancer therapy: Where are we now and where are we going?

Neda Rahimian, Hamid Reza Miraei, Atefeh Amiri, Mohammad Saeid Ebrahimi, Javid Sadri Nahand, Hossein Tarrahimofrad, Michael R Hamblin, Haroon Khan, Hamed Mirzaei

Article1994

What Are We? Where Did We Come From? Where Are We Going?

Luke O'neill, Michael Murphy, Richard B. Gallagher

Science

Editorial Material2022

Ergothioneine, where are we now?

Barry Halliwell, Irwin K. Cheah

Article2022

Reactive oxygen species (ROS), oxygen radicals and antioxidants: Where are we now, where is the field going and where should we go?

Barry Halliwell

Biochemical and Biophysical Research Communications

Article2013

Critical care - where have we been and where are we going?

Jean Louis Vincent

Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?

Discussion(0)

Related publications

Plant-based vaccines and cancer therapy: Where are we now and where are we going?

What Are We? Where Did We Come From? Where Are We Going?

Ergothioneine, where are we now?

Reactive oxygen species (ROS), oxygen radicals and antioxidants: Where are we now, where is the field going and where should we go?

Critical care - where have we been and where are we going?